The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private sector, but not yet in public clinics. The country’s advisory group on ...

The largest US real-world study of BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection successfully met both of its co-primary endpoints, demonstrating that BEYFORTUS provides protection for babies ...

Vermont has the second lowest state fatality rate in the US (148.4 per 100K; Hawaii 113.7/100K). Mississippi (466/100K) and ...

Winter is here, and with it come higher rates of respiratory illnesses. If you've been struck down recently with a sore throat, runny nose and a cough, or perhaps even a fever, you're not alone.

John Stewart, Director of Specialised Commissioning at NHS England said: “For babies born very prematurely, the risk of ...

A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of newborns with severe lung infections. By passing virus-fighting antibodies to ...

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

We explore how some of Australia’s most significant health breakthroughs began right here in Western Australia.

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, ...